# VS Trust: financial statements, quarterly

UVIX · CBOE · CIK 1793497 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uvix.md) · [Financials](/companies/uvix/financials.md) · [Filings](/companies/uvix/filings.md) · [Insiders](/companies/uvix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uvix/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.5](/filings/0001213900-24-027502.md) | [5.0](/filings/0001013762-25-004207.md) | [1.2](/filings/0001213900-26-037527.md) | [125](/filings/0001213900-26-037527.md) |
| Total assets | $m | [175](/filings/0001213900-24-027502.md) | [205](/filings/0001013762-25-004207.md) | [510](/filings/0001213900-26-037527.md) | [551](/filings/0001213900-26-037527.md) |
| Total liabilities | $m | [2.7](/filings/0001213900-24-027502.md) | [10.4](/filings/0001013762-25-004207.md) | [22.0](/filings/0001213900-26-037527.md) | [7.7](/filings/0001213900-26-037527.md) |
| Shareholders' equity | $m | [172](/filings/0001213900-24-027502.md) | [195](/filings/0001013762-25-004207.md) | [488](/filings/0001213900-26-037527.md) | [543](/filings/0001213900-26-037527.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 102,527,473 at 2026-06-30, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-089738.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.